Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11786604 Compounds and compositions for treating HER2 positive tumors

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Lixin Li

Date of Patent

October 17, 2023

Patent Application Number

16878010

Date Filed

May 19, 2020

Patent Citations

US Patent 8337856 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates

US Patent 8552154 Anti-PD-L1 antibodies and uses therefor

US Patent 8575180 9-substituted 8-oxoadenine compound

US Patent 8663643 Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use

US Patent 8779108 Targeted binding agents against B7-H1

US Patent 8951528 Immune response modifier conjugates

US Patent 9259459 Antibody vaccine conjugates and uses therefor

US Patent 9308253 Cancer immunotherapy

...

Patent Primary Examiner

Kristin A Vajda

CPC Code

...

Patent abstract

The present invention relates to compounds for targeted immunotherapy, as well as compositions comprising the same. Further, the present invention relates to the use of the compounds in the treatment of HER2 positive tumors/cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11786604 Compounds and compositions for treating HER2 positive tumors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool